Advertisement
Research Article

Prevention and Mitigation of Acute Radiation Syndrome in Mice by Synthetic Lipopeptide Agonists of Toll-Like Receptor 2 (TLR2)

  • Alexander N. Shakhov mail,

    ashakhov@cbiolabs.com

    Affiliation: Cleveland BioLabs, Inc., Buffalo, New York, United States of America

    X
  • Vijay K. Singh,

    Affiliations: Radiation Countermeasures Program, Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America, Department of Radiation Biology, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America

    X
  • Frederick Bone,

    Affiliation: Cleveland BioLabs, Inc., Buffalo, New York, United States of America

    X
  • Alec Cheney,

    Affiliation: Cleveland BioLabs, Inc., Buffalo, New York, United States of America

    X
  • Yevgeniy Kononov,

    Affiliation: Cleveland BioLabs, Inc., Buffalo, New York, United States of America

    X
  • Peter Krasnov,

    Affiliation: Cleveland BioLabs, Inc., Buffalo, New York, United States of America

    X
  • Troitza K. Bratanova-Toshkova,

    Affiliation: Cleveland BioLabs, Inc., Buffalo, New York, United States of America

    X
  • Vera V. Shakhova,

    Affiliation: Cleveland BioLabs, Inc., Buffalo, New York, United States of America

    X
  • Jason Young,

    Affiliation: Cleveland BioLabs, Inc., Buffalo, New York, United States of America

    X
  • Michael M. Weil,

    Affiliation: Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado, United States of America

    X
  • Angela Panoskaltsis-Mortari,

    Affiliations: Division of Hematology, Oncology and Blood and Marrow Transplant, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, United States of America, Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, United States of America

    X
  • Christie M. Orschell,

    Affiliation: Indiana University School of Medicine, Indianapolis, Indiana, United States of America

    X
  • Patricia S. Baker,

    Affiliation: Cleveland BioLabs, Inc., Buffalo, New York, United States of America

    X
  • Andrei Gudkov,

    Affiliations: Cleveland BioLabs, Inc., Buffalo, New York, United States of America, Roswell Park Cancer Institute, Buffalo, New York, United States of America

    X
  • Elena Feinstein

    Affiliation: Cleveland BioLabs, Inc., Buffalo, New York, United States of America

    X
  • Published: March 27, 2012
  • DOI: 10.1371/journal.pone.0033044

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.